Probiotic-Induced Tolerogenic Dendritic Cells: A Novel Therapy for Inflammatory Bowel Disease?

Inflammatory bowel diseases (IBDs) are immune-mediated, chronic relapsing diseases with a rising prevalence worldwide in both adult and pediatric populations. Treatment options for immune-mediated diseases, including IBDs, are traditional steroids, immunomodulators, and biologics, none of which are...

Descripción completa

Detalles Bibliográficos
Autores principales: Baradaran Ghavami, Shaghayegh, Asadzadeh Aghdaei, Hamid, Sorrentino, Dario, Shahrokh, Shabnam, Farmani, Maryam, Ashrafian, Fatemeh, Dore, Maria Pina, Keshavarz Azizi Raftar, Shahrbanoo, Mobin Khoramjoo, Seyed, Zali, Mohammad Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348973/
https://www.ncbi.nlm.nih.gov/pubmed/34361038
http://dx.doi.org/10.3390/ijms22158274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348973/
https://www.ncbi.nlm.nih.gov/pubmed/34361038
http://dx.doi.org/10.3390/ijms22158274

Ejemplares similares